Publications by authors named "Judith Ertle"

Claim this Profile
H
Hepatic improvement within 27 days of avenciguat treatment in Child-Pugh A cirrhosis detected by an oral cholate challenge test.
Eric J Lawitz, Judith Ertle, Corinna Schoelch, Isabella Gashaw, Michael P McRae

Liver Transpl· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability of transient elastography-based spleen stiffness performed at 100 Hz.
Angelo Armandi, Talal Merizian, Merle Marie Werner, Harvey O Coxson, Tiziana Sanavia, Judith Ertle

Eur Radiol Exp· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study.
Eric J Lawitz, Thomas Reiberger, Jörn M Schattenberg, Corinna Schoelch, Harvey O Coxson, Judith Ertle

Hepatol Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis.
Philip N Newsome, Arun J Sanyal, Guy Neff, Jörn M Schattenberg, Vlad Ratziu, Judith Ertle

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis.
Thomas Reiberger, Annalisa Berzigotti, Jonel Trebicka, Judith Ertle, Isabella Gashaw

Trials· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes.
William L Herring, Ian Gopal Gould, Villum Wittrup-Jensen, Judith Ertle, Effie Kuti

J Comp Eff Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy.
Aglaia Domouchtsidou, Vahé Barsegian, Stefan P Mueller, Jan Best, Judith Ertle

Cancer Immunol Immunother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
Amr El Fouly, Judith Ertle, Ahmed El Dorry, Mohamed K Shaker, Alexander Dechêne

Liver Int· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.
Zhihong Weng, Judith Ertle, Shaoping Zheng, Thomas Lauenstein, Stefan Mueller

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective internal radiation therapy of hepatic tumors: procedural implications of a patent hepatic falciform artery.
Juliane Schelhorn, Judith Ertle, Joerg F Schlaak, Stefan Mueller, Andreas Bockisch

Springerplus· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma.
Christian D Fingas, Akif Altinbas, Martin Schlattjan, Anja Beilfuss, Jan-Peter Sowa, Judith Ertle

Digestion· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma.
Zhihong Weng, Judith Ertle, Shaoping Zheng, Thomas Lauenstein, Stefan Mueller

Oncol Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
Judith M Ertle, Dominik Heider, Marc Wichert, Benedikt Keller, Robert Kueper

Digestion· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery.
Jens M Theysohn, Stefan Müller, Jörg F Schlaak, Judith Ertle, Thomas W Schlosser

Cardiovasc Intervent Radiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma.
Ivonne Nel, Hideo A Baba, Judith Ertle, Frank Weber, Barbara Sitek

Transl Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration.
Jens M Theysohn, Jörg F Schlaak, Stefan Müller, Judith Ertle, Thomas W Schlosser

J Vasc Interv Radiol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable?
Sonja Kinner, Lale Umutlu, Sebastian Blex, Stefan Maderwald, Gerald Antoch, Judith Ertle

Eur J Radiol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.
Judith Ertle, Alexander Dechêne, Jan-Peter Sowa, Volker Penndorf, Kerstin Herzer

Int J Cancer· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
Philip Hilgard, Monia Hamami, Amr El Fouly, André Scherag, Stefan Müller, Judith Ertle

Hepatology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C.
Alisan Kahraman, Johannes Hilsenbeck, Monika Nyga, Judith Ertle, Alexander Wree

Virol J· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis